Afatinib (N=29). | G/E (N=33). | P value | |
---|---|---|---|
Age, median (range) | 66 (36–80) | 68 (41–80) | |
Sex (Male/Female) | 20/9 | 9/24 | 0.0010 |
Histology (Adenocarcinoma) | 29 | 33 | 1.0 |
Smoking (Yes/No) | 13/16 | 8/25 | 0.0126 |
Mutation (19del/ L858R) | 23/6 | 17/16 | 0.0225 |
Stage (III,IV/postoperative recurrence) | 25/4 | 23/10 | 0.1208 |
Treatment with Osimertinib (Yes/No) | 9/20 | 15/18 | 0.2448 |